FDA
-
-
-
-
-
-
-
Athenex Announces MHRA Decision on Oral Paclitaxel
-
-
-
-
-
-
-
ImmunityBio (IBRX) Expands Manufacturing Capacity with State-of-the-Art Manufacturing Plant in New York for Global Pandemic Response and Preparedness
-
-
-
-
-
-
-
Athenex (ATNX) Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel + Encequidar in Metastatic Breast Cancer
-
-
-
-
-
-
-
Athenex Presents Data from Oral Paclitaxel + Pembrolizumab Phase 1 Study at ESMO 2021
-
-
-
-
-
-
-
Athenex Announces Additional Licensing Agreements for Tirbanibulin
-
-
-
-
-
-
-
Athenex (ATNX) Announces Klisyri Receives Positive CHMP Opinion from EMA for Treatment of Actinic Keratosis of Face or Scalp
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Renewable Energy Group, Athenex, Ontrak, and Leidos and Encourages Investors to Contact the Firm
-
249,541 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All